Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesClinical Challenges in Addressing Resistance to Antimicrobial Drugs in the Twenty-First Century
Clinical Pharmacology & Therapeutics, 07/02/09
Septimus EJ et al. - Among the gram-positive pathogens, methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus species are the biggest threats. The situation is even more alarming with respect to gram-negative pathogens, especially because there are currently no late clinical trials involving new anti-infective drugs that are active against these pathogens.
EJ Septimus, 07/06/09
| This article highlights a growing and seriuos challenge which shuold be included in any health care reform. To date, the current proposals on health care reform have failed to adequately address antimicrobial resistance or prevention of hospital infections. Just providing coverage without taking out the waste and harm in our system will not deliver the quality of care politicians always talk about. One of the greatest advances in public health in the last century has been vaccine-preventable diseases and the development of antibiotics to treat seriuos infections. Isn't it ironic that on both these fronts we are now going the wrong direction! |
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Drugs for preventing malaria in travellers
Cochrane Reviews, 10/22/09
Comparison of Gentamicin and Mupirocin in the Prevention of Exit-Site Infection and Peritonitis in Peritoneal Dialysis
Advances in Peritoneal Dialysis, 10/20/09
Empirical Antimicrobial Therapy for Bloodstream Infection Due to Methicillin-Resistant Staphylococcus aureus: No Better than a Coin Toss
Infection Control and Hospital Epidemiology, 10/14/09
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09
Anthracycline- and/or taxane-resistant breast cancer: Results of a literature review to determine the clinical challenges and current treatment trends
Clinical Therapeutics, 10/15/09
VanA-Type Vancomycin-Resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy, 11/05/09
Sponsor
Article Search
Sponsor